ClinicalTrials.gg
Sign In

Thromboembolism clinical trials

The registry lists 288 studies for Thromboembolism across more than 10 countries. 42 are recruiting or about to start. 105 of them are mainly about Thromboembolism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 3 narrower conditions too, such as Venous Thromboembolism: 1,023 studies, 196 open.

Get an email when these change. Save the Thromboembolism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
181
Recruiting
32
Status unknown
31
Terminated
20
Active, not recruiting
8
Not yet recruiting
7

Phase

Phase 3
53
Phase 4
39
Phase 2
27
Phase 1
12
Early Phase 1
1

Where

United States
78
France
46
Germany
40
Canada
38
Spain
34
Italy
29

Who runs them

Bayer (15) · Boehringer Ingelheim (12) · GlaxoSmithKline (9) · Daiichi Sankyo Co., Ltd. (4) · Astellas Pharma Inc (4) · McMaster University (3) · Karolinska Institutet (3) · Inari Medical (3)

What is being tested here

Drugs under test in Thromboembolism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rivaroxaban4917
Tranexamic Acid304
Enoxaparin2213
Warfarin238
Apixaban205
Ticagrelor111
Isoquercitrin111
Argatroban101
Enoxaparin sodium101
Palbociclib101

Drug classes tested here Factor Xa inhibitors 5 open · Thrombolytics 5

Coming up

4phase 3 studies under way
15studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 32 Thromboembolism studies recruiting now, 23 (72%) set no upper age limit and 4 (13%) stop at 75 or younger. 3 (9%) take children under 18. 1 (3%) are for women only and 0 (0%) for men only; 2 (6%) take healthy volunteers.

Recruiting studies that take each age, of 32
AgeWomenMen
101 (3%)1 (3%)
1828 (88%)27 (84%)
3030 (94%)29 (91%)
4030 (94%)29 (91%)
5031 (97%)30 (94%)
6529 (91%)29 (91%)
7528 (88%)28 (88%)
8526 (81%)26 (81%)

Across all 288 studies, recruiting or not: 14% stop at 75 or younger and 7% at 65; 12% take children; 6% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Thromboembolism studies take

Of 46 observational studies under Thromboembolism, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase22 mo17–146 · 20 studies——
Observational39 mo24–65 · 46 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 288. Browse all 288 → or search them.